United States Deferasirox Market Report 2018

June 2018 | 102 pages | ID: U57A242E2CDEN
QYResearch

Abstracts

In this report, the United States Deferasirox market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Deferasirox in these regions, from 2013 to 2025 (forecast).

United States Deferasirox market competition by top manufacturers/players, with Deferasirox sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis
• Cipla
• Sun Pharma
• Natco Pharma

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 500 mg/Tablet
• 250 mg/Tablet
• 125 mg/Tablet
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Transfusional Iron Overload
• NTDT Caused Iron Overload

Contents

United States Deferasirox Market Report 2018

1 DEFERASIROX OVERVIEW

1.1 Product Overview and Scope of Deferasirox
1.2 Classification of Deferasirox by Product Category
  1.2.1 United States Deferasirox Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Deferasirox Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 500 mg/Tablet
  1.2.4 250 mg/Tablet
  1.2.5 125 mg/Tablet
  1.2.6 Others
1.3 United States Deferasirox Market by Application/End Users
  1.3.1 United States Deferasirox Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Transfusional Iron Overload
  1.3.3 NTDT Caused Iron Overload
1.4 United States Deferasirox Market by Region
  1.4.1 United States Deferasirox Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Deferasirox Status and Prospect (2013-2025)
  1.4.3 Southwest Deferasirox Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Deferasirox Status and Prospect (2013-2025)
  1.4.5 New England Deferasirox Status and Prospect (2013-2025)
  1.4.6 The South Deferasirox Status and Prospect (2013-2025)
  1.4.7 The Midwest Deferasirox Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Deferasirox (2013-2025)
  1.5.1 United States Deferasirox Sales and Growth Rate (2013-2025)
  1.5.2 United States Deferasirox Revenue and Growth Rate (2013-2025)

2 UNITED STATES DEFERASIROX MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Deferasirox Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Deferasirox Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Deferasirox Average Price by Players/Suppliers (2013-2018)
2.4 United States Deferasirox Market Competitive Situation and Trends
  2.4.1 United States Deferasirox Market Concentration Rate
  2.4.2 United States Deferasirox Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Deferasirox Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DEFERASIROX SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Deferasirox Sales and Market Share by Region (2013-2018)
3.2 United States Deferasirox Revenue and Market Share by Region (2013-2018)
3.3 United States Deferasirox Price by Region (2013-2018)

4 UNITED STATES DEFERASIROX SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Deferasirox Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Deferasirox Revenue and Market Share by Type (2013-2018)
4.3 United States Deferasirox Price by Type (2013-2018)
4.4 United States Deferasirox Sales Growth Rate by Type (2013-2018)

5 UNITED STATES DEFERASIROX SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Deferasirox Sales and Market Share by Application (2013-2018)
5.2 United States Deferasirox Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES DEFERASIROX PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Deferasirox Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis Deferasirox Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Cipla
  6.2.2 Deferasirox Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cipla Deferasirox Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Sun Pharma
  6.3.2 Deferasirox Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sun Pharma Deferasirox Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Natco Pharma
  6.4.2 Deferasirox Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Natco Pharma Deferasirox Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview

7 DEFERASIROX MANUFACTURING COST ANALYSIS

7.1 Deferasirox Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Deferasirox

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Deferasirox Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Deferasirox Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DEFERASIROX MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Deferasirox Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Deferasirox Sales Volume Forecast by Type (2018-2025)
11.3 United States Deferasirox Sales Volume Forecast by Application (2018-2025)
11.4 United States Deferasirox Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Deferasirox
Figure United States Deferasirox Market Size (M Tablets) by Type (2013-2025)
Figure United States Deferasirox Sales Volume Market Share by Type (Product Category) in 2017
Figure 500 mg/Tablet Product Picture
Figure 250 mg/Tablet Product Picture
Figure 125 mg/Tablet Product Picture
Figure Others Product Picture
Figure United States Deferasirox Market Size (M Tablets) by Application (2013-2025)
Figure United States Sales Market Share of Deferasirox by Application in 2017
Figure Transfusional Iron Overload Examples
Table Key Downstream Customer in Transfusional Iron Overload
Figure NTDT Caused Iron Overload Examples
Table Key Downstream Customer in NTDT Caused Iron Overload
Figure United States Deferasirox Market Size (Million USD) by Region (2013-2025)
Figure The West Deferasirox Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Deferasirox Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Deferasirox Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Deferasirox Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Deferasirox Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Deferasirox Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Deferasirox Sales (M Tablets) and Growth Rate (2013-2025)
Figure United States Deferasirox Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Deferasirox Market Major Players Product Sales Volume (M Tablets) (2013-2018)
Table United States Deferasirox Sales (M Tablets) of Key Players/Suppliers (2013-2018)
Table United States Deferasirox Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Deferasirox Sales Share by Players/Suppliers
Figure 2017 United States Deferasirox Sales Share by Players/Suppliers
Figure United States Deferasirox Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Deferasirox Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Deferasirox Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Deferasirox Revenue Share by Players/Suppliers
Figure 2017 United States Deferasirox Revenue Share by Players/Suppliers
Table United States Market Deferasirox Average Price (USD/Tablet) of Key Players/Suppliers (2013-2018)
Figure United States Market Deferasirox Average Price (USD/Tablet) of Key Players/Suppliers in 2017
Figure United States Deferasirox Market Share of Top 3 Players/Suppliers
Figure United States Deferasirox Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Deferasirox Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Deferasirox Product Category
Table United States Deferasirox Sales (M Tablets) by Region (2013-2018)
Table United States Deferasirox Sales Share by Region (2013-2018)
Figure United States Deferasirox Sales Share by Region (2013-2018)
Figure United States Deferasirox Sales Market Share by Region in 2017
Table United States Deferasirox Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Deferasirox Revenue Share by Region (2013-2018)
Figure United States Deferasirox Revenue Market Share by Region (2013-2018)
Figure United States Deferasirox Revenue Market Share by Region in 2017
Table United States Deferasirox Price (USD/Tablet) by Region (2013-2018)
Table United States Deferasirox Sales (M Tablets) by Type (2013-2018)
Table United States Deferasirox Sales Share by Type (2013-2018)
Figure United States Deferasirox Sales Share by Type (2013-2018)
Figure United States Deferasirox Sales Market Share by Type in 2017
Table United States Deferasirox Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Deferasirox Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Deferasirox by Type (2013-2018)
Figure Revenue Market Share of Deferasirox by Type in 2017
Table United States Deferasirox Price (USD/Tablet) by Types (2013-2018)
Figure United States Deferasirox Sales Growth Rate by Type (2013-2018)
Table United States Deferasirox Sales (M Tablets) by Application (2013-2018)
Table United States Deferasirox Sales Market Share by Application (2013-2018)
Figure United States Deferasirox Sales Market Share by Application (2013-2018)
Figure United States Deferasirox Sales Market Share by Application in 2017
Table United States Deferasirox Sales Growth Rate by Application (2013-2018)
Figure United States Deferasirox Sales Growth Rate by Application (2013-2018)
Table Novartis Basic Information List
Table Novartis Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Novartis Deferasirox Sales Growth Rate (2013-2018)
Figure Novartis Deferasirox Sales Market Share in United States (2013-2018)
Figure Novartis Deferasirox Revenue Market Share in United States (2013-2018)
Table Cipla Basic Information List
Table Cipla Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Cipla Deferasirox Sales Growth Rate (2013-2018)
Figure Cipla Deferasirox Sales Market Share in United States (2013-2018)
Figure Cipla Deferasirox Revenue Market Share in United States (2013-2018)
Table Sun Pharma Basic Information List
Table Sun Pharma Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Sun Pharma Deferasirox Sales Growth Rate (2013-2018)
Figure Sun Pharma Deferasirox Sales Market Share in United States (2013-2018)
Figure Sun Pharma Deferasirox Revenue Market Share in United States (2013-2018)
Table Natco Pharma Basic Information List
Table Natco Pharma Deferasirox Sales (M Tablets), Revenue (Million USD), Price (USD/Tablet) and Gross Margin (2013-2018)
Figure Natco Pharma Deferasirox Sales Growth Rate (2013-2018)
Figure Natco Pharma Deferasirox Sales Market Share in United States (2013-2018)
Figure Natco Pharma Deferasirox Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Deferasirox
Figure Manufacturing Process Analysis of Deferasirox
Figure Deferasirox Industrial Chain Analysis
Table Raw Materials Sources of Deferasirox Major Players/Suppliers in 2017
Table Major Buyers of Deferasirox
Table Distributors/Traders List
Figure United States Deferasirox Sales Volume (M Tablets) and Growth Rate Forecast (2018-2025)
Figure United States Deferasirox Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Deferasirox Price (USD/Tablet) Trend Forecast (2018-2025)
Table United States Deferasirox Sales Volume (M Tablets) Forecast by Type (2018-2025)
Figure United States Deferasirox Sales Volume (M Tablets) Forecast by Type (2018-2025)
Figure United States Deferasirox Sales Volume (M Tablets) Forecast by Type in 2025
Table United States Deferasirox Sales Volume (M Tablets) Forecast by Application (2018-2025)
Figure United States Deferasirox Sales Volume (M Tablets) Forecast by Application (2018-2025)
Figure United States Deferasirox Sales Volume (M Tablets) Forecast by Application in 2025
Table United States Deferasirox Sales Volume (M Tablets) Forecast by Region (2018-2025)
Table United States Deferasirox Sales Volume Share Forecast by Region (2018-2025)
Figure United States Deferasirox Sales Volume Share Forecast by Region (2018-2025)
Figure United States Deferasirox Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources